PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 11800061

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group.
    Sega R.
    Blood Press; 1999; 8(2):114-21. PubMed ID: 10451039
    [Abstract] [Full Text] [Related]

  • 3. Effect of eprosartan and enalapril in the treatment of black hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
    Levine B.
    Curr Med Res Opin; 1999; 15(1):25-32. PubMed ID: 10216808
    [Abstract] [Full Text] [Related]

  • 4. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
    Punzi HA, Punzi CF.
    J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
    Hedner T, Himmelmann A.
    J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
    Gavras I, Gavras H.
    Curr Med Res Opin; 1999 Jan; 15(1):15-24. PubMed ID: 10216807
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E, Bombelli M, Cerasola G, Cipollone F, Ferri C, Grazioli I, Leprotti C, Mancia G, Melzi G, Mugellini A, Mulè G, Palasciano G, Salvetti A, Trimarco B.
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [Abstract] [Full Text] [Related]

  • 11. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group.
    Elliott WJ.
    J Hum Hypertens; 1999 Jun; 13(6):413-7. PubMed ID: 10408592
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Eprosartan Study Group.
    Diamond JA, Gharavi A, Roychoudhury D, Machac J, Henzlova MJ, Travis A, Phillips RA.
    Curr Med Res Opin; 1999 Jun; 15(1):1-8. PubMed ID: 10216805
    [Abstract] [Full Text] [Related]

  • 14. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
    Breeze E, Rake EC, Donoghue MD, Fletcher AE.
    J Hum Hypertens; 2001 Dec; 15(12):857-62. PubMed ID: 11773988
    [Abstract] [Full Text] [Related]

  • 15. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
    Rake EC, Breeze E, Fletcher AE.
    J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
    [Abstract] [Full Text] [Related]

  • 16. Eprosartan: a review of its use in the management of hypertension.
    Plosker GL, Foster RH.
    Drugs; 2000 Jul; 60(1):177-201. PubMed ID: 10929934
    [Abstract] [Full Text] [Related]

  • 17. Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension.
    Puig JG, Mateos F, Buño A, Ortega R, Rodriguez F, Dal-Ré R.
    J Hypertens; 1999 Jul; 17(7):1033-9. PubMed ID: 10419078
    [Abstract] [Full Text] [Related]

  • 18. Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
    Conter HS, McKay DW, Reiz RJ.
    Can J Cardiol; 2004 Oct; 20 Suppl C():6C-10C. PubMed ID: 16807617
    [Abstract] [Full Text] [Related]

  • 19. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
    Teitelbaum I, Chilvers M, Reiz RJ.
    Can J Cardiol; 2004 Oct; 20 Suppl C():11C-16C. PubMed ID: 16807618
    [Abstract] [Full Text] [Related]

  • 20. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.
    Himmelmann A, Keinänen-Kiukaanniemi S, Wester A, Redón J, Asmar R, Hedner T, Effect Study Group.
    Blood Press; 2001 Oct; 10(1):43-51. PubMed ID: 11332334
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.